Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications

被引:10
|
作者
Friberger, Ida [1 ]
Jussing, Emma [2 ,3 ]
Han, Jinming [1 ,4 ]
Goos, Jeroen A. C. M. [1 ,2 ,3 ]
Siikanen, Jonathan [2 ,5 ]
Kaipe, Helen [6 ,7 ]
Lambert, Melanie [8 ]
Harris, Robert A. [1 ,4 ]
Samen, Erik [2 ,3 ]
Carlsten, Mattias [8 ,9 ]
Holmin, Staffan [1 ,10 ]
Tran, Thuy A. [1 ,2 ,3 ]
机构
[1] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[2] Karolinska Inst, Dept Oncol & Pathol, Stockholm, Sweden
[3] Karolinska Univ Hosp, Dept Radiopharm, Stockholm, Sweden
[4] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden
[5] Karolinska Univ Hosp, Dept Med Radiat Phys & Nucl Med, Stockholm, Sweden
[6] Karolinska Inst, Dept Lab Med, Stockholm, Sweden
[7] Karolinska Univ Hosp, Dept Clin Immunol & Transfus Med, Stockholm, Sweden
[8] Karolinska Inst, Dept Med Huddinge, Stockholm, Sweden
[9] Karolinska Univ Hosp, Ctr Cell Therapy & Allogene Stem Cell Transplanta, Stockholm, Sweden
[10] Karolinska Univ Hosp, Dept Neuroradiol, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
Cell labelling; Cell tracking; Zr-89; Oxine; Deferoxamine; PET; Imaging; DONOR LYMPHOCYTE INFUSION; DECIDUAL STROMAL CELLS; TRACKING; LEUKOCYTES; PET; CYTOTOXICITY; LEUKEMIA; RELAPSE;
D O I
10.1007/s11307-021-01622-z
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background There is a need to better characterise cell-based therapies in preclinical models to help facilitate their translation to humans. Long-term high-resolution tracking of the cells in vivo is often impossible due to unreliable methods. Radiolabelling of cells has the advantage of being able to reveal cellular kinetics in vivo over time. This study aimed to optimise the synthesis of the radiotracers [Zr-89]Zr-oxine (8-hydroxyquinoline) and [Zr-89]Zr-DFO-NCS (p-SCN-Bn-Deferoxamine) and to perform a direct comparison of the cell labelling efficiency using these radiotracers. Procedures Several parameters, such as buffers, pH, labelling time and temperature, were investigated to optimise the synthesis of [Zr-89]Zr-oxine and [Zr-89]Zr-DFO-NCS in order to reach a radiochemical conversion (RCC) of >95 % without purification. Radio-instant thin-layer chromatography (iTLC) and radio high-performance liquid chromatography (radio-HPLC) were used to determine the RCC. Cells were labelled with [Zr-89]Zr-oxine or [Zr-89]Zr-DFO-NCS. The cellular retention of Zr-89 and the labelling impact was determined by analysing the cellular functions, such as viability, proliferation, phagocytotic ability and phenotypic immunostaining. Results The optimised synthesis of [Zr-89]Zr-oxine and [Zr-89]Zr-DFO-NCS resulted in straightforward protocols not requiring additional purification. [Zr-89]Zr-oxine and [Zr-89]Zr-DFO-NCS were synthesised with an average RCC of 98.4 % (n = 16) and 98.0 % (n = 13), respectively. Cell labelling efficiencies were 63.9 % (n = 35) and 70.2 % (n = 30), respectively. Zr-89 labelling neither significantly affected the cell viability (cell viability loss was in the range of 1-8 % compared to its corresponding non-labelled cells, P value > 0.05) nor the cells' proliferation rate. The phenotype of human decidual stromal cells (hDSC) and phagocytic function of rat bone-marrow-derived macrophages (rMac) was somewhat affected by radiolabelling. Conclusions Our study demonstrates that [Zr-89]Zr-oxine and [Zr-89]Zr-DFO-NCS are equally effective in cell labelling. However, [Zr-89]Zr-oxine was superior to [Zr-89]Zr-DFO-NCS with regard to long-term stability, cellular retention, minimal variation between cell types and cell labelling efficiency.
引用
收藏
页码:952 / 962
页数:11
相关论文
共 50 条
  • [41] [89Zr]Oxinate4 for long-term in vivo cell tracking by positron emission tomography
    Charoenphun, Putthiporn
    Meszaros, Levente K.
    Chuamsaamarkkee, Krisanat
    Sharif-Paghaleh, Ehsan
    Ballinger, James R.
    Ferris, Trevor J.
    Went, Michael J.
    Mullen, Gregory E. D.
    Blower, Philip J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (02) : 278 - 287
  • [42] [89Zr]Oxinate4 for long-term in vivo cell tracking by positron emission tomography
    Putthiporn Charoenphun
    Levente K. Meszaros
    Krisanat Chuamsaamarkkee
    Ehsan Sharif-Paghaleh
    James R. Ballinger
    Trevor J. Ferris
    Michael J. Went
    Gregory E. D. Mullen
    Philip J. Blower
    European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 278 - 287
  • [43] [89Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3trial
    Shuch, Brian
    Pantuck, Allan J.
    Bernhard, Jean-Christophe
    Morris, Michael A.
    Master, Viraj
    Scott, Andrew M.
    van Praet, Charles
    Bailly, Clement
    Onal, Buelent
    Aksoy, Tamer
    Merkx, Robin
    Schuster, David M.
    Lee, Sze Ting
    Pandit-Taskar, Neeta
    Fan, Alice C.
    Allman, Phillip
    Schmidt, Karl
    Tauchmanova, Libuse
    Wheatcroft, Michael
    Behrenbruch, Christian
    Hayward, Colin R. W.
    Mulders, Peter
    LANCET ONCOLOGY, 2024, 25 (10): : 1277 - 1287
  • [44] Fully Automated Radiosynthesis of [89Zr]Zr-Crefmirlimab Berdoxam for Clinical Multi-Centre PET Imaging of CD8+ T-Cell Trafficking
    Wichmann, C.
    Cao, Z.
    McDonald, A.
    Guo, N.
    Poniger, S.
    Scott, F.
    Jia, F.
    Brady, K.
    Le, W.
    Scott, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S223 - S223
  • [45] OPTIMISATION OF PRODUCTION & PURIFICATION OF THE LONG-HALFLIFE RADIOMETAL PET ISOTOPE 89ZR: TOWARDS PROVISION OF A NATIONAL RESOURCE FOR PRECLINICAL IMAGING APPLICATIONS
    Scharli, Rainer
    Chan, Sun
    Jeffery, Charmaine
    Asad, Ali
    Morandeau, Laurence
    Price, Roger
    INTERNAL MEDICINE JOURNAL, 2013, 43 : 35 - 36
  • [46] Radiation Dosimetry Study of [89Zr]rituximab Tracer for Clinical Translation of B cell NHL Imaging using Positron Emission Tomography
    Natarajan, Arutselvan
    Gambhir, Sanjiv Sam
    MOLECULAR IMAGING AND BIOLOGY, 2015, 17 (04) : 539 - 547
  • [47] 89Zr labelled nanoparticle coating with biotin inserted cell membrane as a biomaterial for enhancing long-term circulation and tumor targeting
    Lee, J.
    Choi, P.
    Hur, M.
    Yang, S.
    Kong, Y.
    Lee, E.
    Song, H.
    Park, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S738 - S738
  • [48] Radiation Dosimetry Study of [89Zr]rituximab Tracer for Clinical Translation of B cell NHL Imaging using Positron Emission Tomography
    Arutselvan Natarajan
    Sanjiv Sam Gambhir
    Molecular Imaging and Biology, 2015, 17 : 539 - 547
  • [49] Zirconium-89 (89Zr)-labeled bispecific T-cell engager (BiTE®) AMG 211 PET imaging to determine AMG 211 biodistribution in patients with gastrointestinal (GI) adenocarcinomas
    Moek, K. L.
    Waaijer, S. J. H.
    Kok, I. C.
    Suurs, F. V.
    Brouwers, A.
    van Oordt, C. W. Menke-van der Houven
    Wind, T. T.
    Gietema, J. A.
    Schroder, C. P.
    Mahesh, S. V. K.
    Jorritsma-Smit, A.
    Hooge, M. N. Lub-De
    Fehrmann, R. S. N.
    de Groot, D. J.
    de Vries, E. G. E.
    ANNALS OF ONCOLOGY, 2018, 29
  • [50] Immuno-PET imaging using 89Zr labeled PD-L1 antibody in non-small cell lung cancer Xenograft
    Li, Dan
    Zhu, Xiao-Hua
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57